Alps Group Inc (ALPS) stock
Close on Nov 12, 2026Market cap $195.52MP/E –Yield –
Alps Group Inc grew revenue 44.1% to $4.86M over fiscal 2026. Free cash flow was -$2.63M. At the latest close the market valued the company at $195.52M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- $195.52M
- P/E ratio
- –
- Price to sales
- 40.26
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1.35%
Fundamentals
- Revenue
- $4.86M
- Net income
- -$2.01M
- EPS, diluted
- -$0.02
- Free cash flow
- -$2.63M
Trading
- Previous close
- $1.19
- Open
- $1.19
- Day's range
- $1.10 – $1.21
- Volume
- 38,793
- Average volume (20 days)
- 23,316
- Beta (5 years)
- 0.23
- 52-week range
- $0.23 – $8.60
- RSI (14 days)
- 43.7
- Volatility (1 year)
- 2536.5%
- Relative volume
- 1.25×
- WACC
- 7.4%
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ALPS | S&P 500 | Difference | ALPS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +231.2% | -2.7% | +233.9 pts | ||
| 3 months | +228.2% | -1.7% | +230.0 pts | ||
| Year to date | -73.0% | +11.9% | −84.9 pts | ||
| 1 year | -71.3% | +12.0% | −83.3 pts | ||
| 3 years | -97.8% | +78.2% | −176.0 pts | -72.1% | +21.2% |
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Alps filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Alps
Services-Health Services
ALPS GROUP INC is an enterprise operating primarily across two core segments: Medical and Wellness, and Life Science. Through its specialized subsidiaries and laboratory facilities, the company provides cellular therapy, medical testing laboratory services, and aesthetic beauty procedures. In addition, it generates revenue by providing clinical and healthcare consultations, as well as supplying medicine, healthcare products, and related medical consumables. These offerings serve individual patients seeking medical and wellness treatments along with institutional healthcare and research clients.
Company profile, executives and historyAlps stock: common questions
What is Alps's stock price?
ALPS closed at $1.18 on Nov 12, 2026, down 1.26% on the day. Over the past 52 weeks it traded between $0.23 and $8.60.
What is Alps's market cap?
Alps was worth $195.52M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is ALPS's P/E ratio?
Alps lost money over fiscal 2026 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does Alps make?
Alps reported revenue of $4.86M for fiscal 2026, up 44.1% from a year earlier.
Does Alps pay a dividend?
No. Alps has not paid a cash dividend over the last twelve months.
How has ALPS stock performed over the past year?
Including dividends, ALPS returned -71.3% over the past year, against +12.0% for the S&P 500.
Who are Alps's competitors?
Companies most similar to Alps by business, industry and size include EUDA, ATPC, LDDD, MCTA, VSEE.
See a number that looks wrong?